Oncology Central

Comprehensive CAR T-cell therapy pediatric guidelines developed

Approximately 1 year after the US FDA approved CAR T-cell therapy for children with acute lymphoblastic leukemia (ALL), researchers at The University of Texas MD Anderson Cancer Center (TX, USA) and the Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI) have published treatment guidelines for managing the treatment in Nature Reviews Clinical Oncology.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.





News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.